ACHILLION PHARMACEUTICALS INC
DelistedCIK 1070336fmd_0HGKCT93Y91X0YYTN769307SGGManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2019, 39 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | (0) | 2 | 0 | 3 | – | – | 66 | 15 | – | – |
| Research and development | 18 | 21 | 35 | 39 | 47 | 54 | 57 | 57 | 64 | 50 |
| Total operating expenses | 25 | 28 | 45 | 50 | 59 | 69 | 81 | 80 | 90 | 76 |
| Operating income | (26) | (25) | (44) | (47) | (59) | (69) | (15) | (65) | (90) | (76) |
| Interest expense | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest and investment income | – | 0 | 0 | 0 | – | – | – | – | – | – |
| Net income | (26) | (25) | (44) | (47) | (59) | (69) | (5) | (62) | (85) | (70) |